Bang & Olufsen A/S
21.3.2026 21:09:25 CET | Globenewswire | Press release
Major Shareholder Announcement
Major Shareholder Announcement
Bang & Olufsen A/S has, pursuant to the Danish Capital Markets Act, received a major shareholder notification from UBS Group AG.
- As per 17 March 2026, UBS Group AG’s holding of shares and voting rights pursuant to section 38 of the Danish Capital Markets Act, as well as other financial instruments pursuant to section 39(2), was above 5 percent of the total share capital and voting rights in Bang & Olufsen A/S.
As of 17 March 2026, UBS Group AG held a total of 7,369,101 shares and voting rights in Bang & Olufsen A/S, corresponding to 5.002 percent of the total share capital and voting rights.
For further information, please contact:
Cristina Rønde Hefting
Sr. Director, Head of Strategy & Investor Relations
Phone: +45 4153 7303
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chery Group8.10.2026 01:08:30 CEST | Press release
FREELANDER Details Powertrain, Battery and All-Terrain Technology for International Left-Hand Drive FREELANDER 8
Chongqing Changan Automobile Co., Ltd.7.10.2026 21:38:36 CEST | Press release
Changan Automobile to Make Major Announcements at Mondial de l'Auto 2026
Oma Säästöpankki Oyj7.10.2026 20:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of S-Bank Plc in Oma Savings Bank Plc has exceeded 90 percent
Oma Säästöpankki Oyj7.10.2026 19:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Parkanon Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
Zealand Pharma7.10.2026 19:13:53 CEST | Press release
Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom